0001209191-21-024234.txt : 20210401 0001209191-21-024234.hdr.sgml : 20210401 20210401181957 ACCESSION NUMBER: 0001209191-21-024234 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210330 FILED AS OF DATE: 20210401 DATE AS OF CHANGE: 20210401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xu Stella CENTRAL INDEX KEY: 0001728741 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40288 FILM NUMBER: 21799758 MAIL ADDRESS: STREET 1: C/O ARMO BIOSCIENCES, INC. STREET 2: 575 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Design Therapeutics, Inc. CENTRAL INDEX KEY: 0001807120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823929248 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 991C LOMAS SANTA FE #436 CITY: SOLANA BEACH STATE: CA ZIP: 92121 BUSINESS PHONE: 858-293-4900 MAIL ADDRESS: STREET 1: 991C LOMAS SANTA FE #436 CITY: SOLANA BEACH STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-30 0 0001807120 Design Therapeutics, Inc. DSGN 0001728741 Xu Stella C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110 CARLSBAD CA 92011 1 0 1 0 Common Stock 2021-03-30 4 C 0 4439839 A 4439839 I See footnote Common Stock 2021-03-30 4 C 0 280991 A 4720830 I See footnote Common Stock 2021-03-30 4 P 0 10000 20.00 A 4730830 I By spouse Series A Preferred Stock 2021-03-30 4 C 0 7236938 0.00 D Common Stock 4439839 0 I See footnote Series B Preferred Stock 2021-03-30 4 C 0 458016 0.00 D Common Stock 280991 0 I See footnote All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date. The general partner of Quan Venture Fund II, L.P. is Quan Venture Partners II, L.L.C. Stella Xu is a managing director of Quan Venture Partners II, L.L.C. and shares the ultimate power to vote or dispose of the shares held by Quan Venture Fund II, L.P. Dr. Xu disclaims beneficial ownership of the shares held by Quan Venture Fund II, L.P., except to the extent of her pecuniary interest. The shares were purchased in the Issuer's initial public offering. /s/ Mustapha Parekh, Attorney-in-Fact 2021-03-31